Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
Public ClinicalTrials.gov record NCT01201928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multicenter, Clinical Trial to Evaluate Pulmonary Function in a Subset of Subjects With Type 1 or Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate pulmonary function test (PFT) sub-study in interested subjects from studies MKC-TI-161, MKC-TI-162 and MKC-TI-166. 100 Type I and 100 Type II diabetics will be enrolled. Each subject will undergo 6 PFT assessments over the course of the parent study.
Study identification
- NCT ID
- NCT01201928
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2010 (Type not available)
- Primary completion
- Mar 2011 (Actual)
- Completion
- Mar 2012 (Actual)
- Last update posted
- Dec 6, 2012
2010 – 2012
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valley Research | Fresno | California | 93720 | — |
| Health Care Partners Medical Group | Long Beach | California | 90806 | — |
| Laureate Clinical Research Group | Atlanta | Georgia | 30308 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30309 | — |
| Alta Pharmaceutical Research Center | Dunwoody | Georgia | 30338 | — |
| LaPorte County Institute for Clinical Research Inc. | Michigan City | Indiana | 46360 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Billings Clinic Research Center | Billings | Montana | 59101 | — |
| Winthrop University Hospital | Mineola | New York | 11501 | — |
| North Shore Diabetes and Endocrine Associates | New Hyde Park | New York | 11042 | — |
| Endocrine Research Physicians East PA | Greenville | North Carolina | 27834 | — |
| Israel Hartman MD | Arlington | Texas | 76014 | — |
| Dallas Diabetes & Endocrine Center | Dallas | Texas | 75230 | — |
| SAM Clinical Research Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01201928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2012 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01201928 live on ClinicalTrials.gov.